Pathstone Holdings
MDT icon

Pathstone Holdings’s Medtronic MDT Stock Holding History

Pathstone Holdings’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Sell
151,553
-3,596
-2% -$290K 0.03% 345
2026
Q1 		$13.5M Buy
155,149
+30,344
+24% +$2.91M 0.05% 250
2025
Q4 		$12M Sell
124,805
-7,558
-6% -$734K 0.05% 282
2025
Q3 		$12.6M Buy
132,363
+7,681
+6% +$706K 0.05% 271
2025
Q2 		$10.9M Buy
124,682
+4,799
+4% +$407K 0.04% 300
2025
Q1 		$10.8M Buy
119,883
+11,216
+10% +$1M 0.05% 319
2024
Q4 		$8.69M Sell
108,667
-17,136
-14% -$1.48M 0.04% 362
2024
Q3 		$11.3M Sell
125,803
-4,129
-3% -$347K 0.05% 290
2024
Q2 		$10.2M Sell
129,932
-5,229
-4% -$429K 0.05% 293
2024
Q1 		$11.8M Buy
135,161
+40,109
+42% +$3.42M 0.05% 261
2023
Q4 		$7.86M Buy
+95,052
New +$7.24M 0.04% 308

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pathstone Holdings's MDT Position: Q2 2026 in Review

Pathstone Holdings reduced its Medtronic (MDT) stake by 2.3% in Q2 2026, selling an estimated $290K and leaving 151,553 shares worth $11.9M. The position accounts for 0.03% of the portfolio, ranked #345.

Pathstone Holdings first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.5M in Q1 2026. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Pathstone Holdings held 151,553 shares of Medtronic worth $11.9M as of Q2 2026.
  • Pathstone Holdings sold 3,596 Medtronic shares in Q2 2026, an estimated $290K.
  • Medtronic made up 0.03% of Pathstone Holdings's portfolio in Q2 2026, its #345 holding.
  • Pathstone Holdings first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Medtronic position peaked at $13.5M in Q1 2026.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.